Iron imports. IV. Hepcidin and regulation of body iron metabolism

被引:250
作者
Ganz, T
Nemeth, E
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2006年 / 290卷 / 02期
关键词
nutrition; hemochromatosis; anemia;
D O I
10.1152/ajpgi.00412.2005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepcidin, a small peptide synthesized in the liver, controls extracellular iron by regulating its intestinal absorption, placental transport, recycling by macrophages, and release from stores. Hepcidin inhibits the cellular efflux of iron by binding to and inducing the degradation of ferroportin, the sole iron exporter in iron-transporting cells. In turn, hepcidin synthesis is increased by iron loading and decreased by anemia and hypoxia. Hepcidin is markedly induced during inflammation, trapping iron in macrophages, decreasing plasma iron concentrations, and contributing to the anemia of inflammation. Hepcidin deficiency due to the dysregulation of its synthesis causes most known forms of hemochromatosis.
引用
收藏
页码:G199 / G203
页数:5
相关论文
共 26 条
  • [1] Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
    Bridle, KR
    Frazer, DM
    Wilkins, SJ
    Dixon, JL
    Purdie, DM
    Crawford, DHG
    Subramaniam, VN
    Powell, LW
    Anderson, GJ
    Ramm, GA
    [J]. LANCET, 2003, 361 (9358) : 669 - 673
  • [2] The molecular basis of ferroportin-linked hemochromatosis
    De Domenico, I
    Ward, DM
    Nemeth, E
    Vaughn, MB
    Musci, G
    Ganz, T
    Kaplan, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (25) : 8955 - 8960
  • [3] Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin
    Drakesmith, H
    Schimanski, LM
    Ormerod, E
    Merryweather-Clarke, AT
    Viprakasit, V
    Edwards, JP
    Sweetland, E
    Bastin, JM
    Cowley, D
    Chinthammitr, Y
    Robson, KJH
    Townsend, ARM
    [J]. BLOOD, 2005, 106 (03) : 1092 - 1097
  • [4] Mechanisms of iron accumulation in hereditary hemochromatosis
    Fleming, RE
    Sly, WS
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2002, 64 : 663 - 680
  • [5] Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats
    Frazer, DM
    Wilkins, SJ
    Becker, EM
    Vulpe, CD
    McKie, AT
    Trinder, D
    Anderson, GJ
    [J]. GASTROENTEROLOGY, 2002, 123 (03) : 835 - 844
  • [6] The orchestration of body iron intake: how and where do enterocytes receive their cues?
    Frazer, DM
    Anderson, GJ
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2003, 30 (03) : 288 - 297
  • [7] Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron
    Gehrke, SG
    Kulaksiz, H
    Herrmann, T
    Riedel, HD
    Bents, K
    Veltkamp, C
    Stremmel, W
    [J]. BLOOD, 2003, 102 (01) : 371 - 376
  • [8] The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis
    Hunter, HN
    Fulton, DB
    Ganz, T
    Vogel, HJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) : 37597 - 37603
  • [9] LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
    Krause, A
    Neitz, S
    Mägert, HJ
    Schulz, A
    Forssmann, WG
    Schulz-Knappe, P
    Adermann, K
    [J]. FEBS LETTERS, 2000, 480 (2-3) : 147 - 150
  • [10] Functional differences between hepcidin 1 and 2 in transgenic mice
    Lou, DQ
    Nicolas, G
    Lesbordes, JC
    Viatte, L
    Grimber, G
    Szajnert, MF
    Kahn, A
    Vaulont, S
    [J]. BLOOD, 2004, 103 (07) : 2816 - 2821